1. Home
  2. TU vs ILMN Comparison

TU vs ILMN Comparison

Compare TU & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telus Corporation

TU

Telus Corporation

HOLD

Current Price

$12.65

Market Cap

22.9B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$137.67

Market Cap

18.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TU
ILMN
Founded
1993
1998
Country
Canada
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical Specialities
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9B
18.9B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
TU
ILMN
Price
$12.65
$137.67
Analyst Decision
Hold
Hold
Analyst Count
3
16
Target Price
$18.17
$116.19
AVG Volume (30 Days)
7.5M
1.8M
Earning Date
11-07-2025
02-05-2026
Dividend Yield
9.41%
N/A
EPS Growth
24.25
N/A
EPS
0.56
4.46
Revenue
$14,679,551,147.00
$4,288,000,000.00
Revenue This Year
$2.93
N/A
Revenue Next Year
$2.49
$2.08
P/E Ratio
$22.64
$30.22
Revenue Growth
2.42
N/A
52 Week Low
$12.54
$68.70
52 Week High
$16.74
$153.06

Technical Indicators

Market Signals
Indicator
TU
ILMN
Relative Strength Index (RSI) 28.17 67.61
Support Level $12.54 $129.29
Resistance Level $12.96 $137.09
Average True Range (ATR) 0.23 3.94
MACD 0.01 -0.37
Stochastic Oscillator 10.85 91.74

Price Performance

Historical Comparison
TU
ILMN

About TU Telus Corporation

Telus is one of the Big Three wireless service providers in Canada, with over 10 million mobile phone subscribers nationwide constituting almost 30% of the total market. It is the incumbent local exchange carrier in the western Canadian provinces of British Columbia and Alberta, where it provides internet, television, and landline phone services. It also has a small wireline presence in eastern Quebec. Mostly because of recent acquisitions, more than 20% of Telus' sales now come from nontelecom businesses, most notably in the international business services, health, security, and agriculture industries. The firm has a 55% economic stake in Telus International.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: